Cost Affordability Management

Cost affordability pressure is converging on post-acute utilization, bundled payments, and Medicaid waiver discipline: the HHS OIG’s finding that UnitedHealth, Humana, and CVS denied Medicare Advantage prior authorization requests for LTACH and inpatient rehab at elevated rates is intensifying the payer-provider tension around whether MA “cost control” is drifting into access restriction for high-cost post-acute care (OIG/MA prior auth analysis). At the same time, CMS under the Trump administration is pushing harder on fiscal guardrails—most notably budget neutrality for Medicaid Section 1115 waivers—while CJR-X commentary underscores that hospitals entering episode-based models will need tighter data, discharge, and post-acute management infrastructure to protect margins under mandatory or quasi-mandatory risk (CJR-X data strategy). For VBC leaders, the week’s pattern is clear: affordability management is moving from broad “total cost of care” rhetoric into sharper operational battlegrounds—prior auth integrity, post-acute network steering, waiver financing, admissions/readmissions reduction, and high-cost obesity/GLP-1 population strategy.